January 21, 2005 — In mid-January, the US Food and Drug Administration (FDA) and Wyeth Pharmaceuticals sent out "Dear Doctor" and "Dear Pharmacist" letters notifying recipients that a new medication ...
Amiodarone’s Strong Antiarrhythmic Efficacy Has Sustained Its Use in Atrial Fibrillation, Despite Its Association With Adverse Events, According to Findings from Decision Resources BURLINGTON, Mass.-- ...
TORONTO -- Data published in the New England Journal of Medicine by St. Michael's Hospital/University of Toronto researchers demonstrates that the anti-arrhythmic agent IV amiodarone is almost twice ...
Perfluorooctanoic Acid Level Tied to Cardiovascular Disease Amiodarone treatment for arrhythmias is associated with a higher risk of developing cancer, particularly in males and with increasing dose. ...
Damirbek Osmonov, M.D; Izzet Erdinler, M.D; Kazim Serhan Ozcan, M.D; Servet Altay, M.D; Ceyhan Turkkan, M.D; Ersin Yildirim, M.D; Hakan Hasdemir, M.D; Ahmet Taha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback